NCT00949884
Olmesartan Comparison to Losartan in Hypertensive Subjects
See it on ClinicalTrials.gov ↗941 people
45.5%
54.5%
428 womenmiddle line = equal numbers513 men
- Phase
- PHASE4
- Paid for by
- Daiichi Sankyo
- Finished
- 2010-01
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 51.9 years
- Age 65+
- 8.7%
- Weight (BMI)
- mean 32.41 kilogram/meter^2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 64.8% · Black / African American 28.4% · Asian 5.6% · American Indian / Alaska Native 0.6% · Not reported 0.3% · Native Hawaiian / Pacific Islander 0.2% · More than one race 0%
Women left out
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Subjects with a history of myocardial infarction, angina, coronary angioplasty, bypass surgery or heart failure within the last 12 months.”
- No diabetes
Women with diabetes were turned away.
“Subjects with type 2 diabetes mellitus with an HbA1c ≥ 9.5% at Screening.”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“…/metabolic (with the exception of non-insulin, dependent type 2 diabetes mellitus with HbA1c \< 9.5% at Screening), hematologic/oncologic (including an active malignancy other than basal cell carcinoma), neurologic and psychiatric diseases.”
- No cancer
Women with current or past cancer were turned away.
“…/metabolic (with the exception of non-insulin, dependent type 2 diabetes mellitus with HbA1c \< 9.5% at Screening), hematologic/oncologic (including an active malignancy other than basal cell carcinoma), neurologic and psychiatric diseases.”
Study titles and rules are shown in their original English.